High-dose chemotherapy plus autologous stem-cell transplantation as consolidation therapy in patients with relapsed multiple myeloma after previous autologous stem-cell transplantation (NCRI Myeloma X Relapse [Intensive trial]): a randomised, open-label, phase 3 trial

Publication | Open Access

DOI Full Paper Access

151

Citations

References

2014

Year

Gordon Cook, Cathy Williams, Julia Brown, David A. Cairns, Jamie Cavenagh, John A. Snowden, A. John Ashcroft, Marie Fletcher, Christopher Parrish, Kwee Yong,

The Lancet Oncology

Hematological MalignancyTransplantationMarrow TransplantationMedicineHematologyCell Replacement TherapyConsolidation TherapyHigh-dose ChemotherapyRadiation OncologyOncologyCell TransplantationAutologous Stem-cell TransplantationHealth Sciences